2075 related articles for article (PubMed ID: 19167595)
41. Efficacy, safety, and tolerability of the cyclooxygenase-inhibiting nitric oxide donator naproxcinod in treating osteoarthritis of the hip or knee.
Karlsson J; Pivodic A; Aguirre D; Schnitzer TJ
J Rheumatol; 2009 Jun; 36(6):1290-7. PubMed ID: 19411388
[TBL] [Abstract][Full Text] [Related]
42. Transdermal fentanyl for improvement of pain and functioning in osteoarthritis: a randomized, placebo-controlled trial.
Langford R; McKenna F; Ratcliffe S; Vojtassák J; Richarz U
Arthritis Rheum; 2006 Jun; 54(6):1829-37. PubMed ID: 16729276
[TBL] [Abstract][Full Text] [Related]
43. Efficacy and safety of tramadol/acetaminophen tablets (Ultracet) as add-on therapy for osteoarthritis pain in subjects receiving a COX-2 nonsteroidal antiinflammatory drug: a multicenter, randomized, double-blind, placebo-controlled trial.
Emkey R; Rosenthal N; Wu SC; Jordan D; Kamin M;
J Rheumatol; 2004 Jan; 31(1):150-6. PubMed ID: 14705234
[TBL] [Abstract][Full Text] [Related]
44. Efficacy and tolerability of celecoxib compared with diclofenac slow release in the treatment of acute ankle sprain in an Asian population.
Nadarajah A; Abrahan L; Lau FL; Hwang LJ; Fakir-Bolte C
Singapore Med J; 2006 Jun; 47(6):534-42. PubMed ID: 16752024
[TBL] [Abstract][Full Text] [Related]
45. A comparison of the efficacy and safety of celecoxib 200 mg and celecoxib 400 mg once daily in treating the signs and symptoms of psoriatic arthritis.
Kivitz AJ; Espinoza LR; Sherrer YR; Liu-Dumaw M; West CR
Semin Arthritis Rheum; 2007 Dec; 37(3):164-73. PubMed ID: 17570469
[TBL] [Abstract][Full Text] [Related]
46. Use of the lidocaine patch 5% in reducing intensity of various pain qualities reported by patients with low-back pain.
Galer BS; Gammaitoni AR; Oleka N; Jensen MP; Argoff CE
Curr Med Res Opin; 2004; 20 Suppl 2():S5-12. PubMed ID: 15563741
[TBL] [Abstract][Full Text] [Related]
47. Efficacy and safety of E-OA-07 in moderate to severe symptoms of osteoarthritis: a double-blind randomized placebo-controlled study.
Kulkarni MP; Shakeel A; Shinde BS; Rosenbloom RA
Am J Ther; 2011; 18(2):170-7. PubMed ID: 21317618
[TBL] [Abstract][Full Text] [Related]
48. A randomized crossover trial of a wedged insole for treatment of knee osteoarthritis.
Baker K; Goggins J; Xie H; Szumowski K; LaValley M; Hunter DJ; Felson DT
Arthritis Rheum; 2007 Apr; 56(4):1198-203. PubMed ID: 17393448
[TBL] [Abstract][Full Text] [Related]
49. Efficacy and safety of low-dose transdermal buprenorphine patches (5, 10, and 20 microg/h) versus prolonged-release tramadol tablets (75, 100, 150, and 200 mg) in patients with chronic osteoarthritis pain: a 12-week, randomized, open-label, controlled, parallel-group noninferiority study.
Karlsson M; Berggren AC
Clin Ther; 2009 Mar; 31(3):503-13. PubMed ID: 19393841
[TBL] [Abstract][Full Text] [Related]
50. Equivalence study of a topical diclofenac solution (pennsaid) compared with oral diclofenac in symptomatic treatment of osteoarthritis of the knee: a randomized controlled trial.
Tugwell PS; Wells GA; Shainhouse JZ
J Rheumatol; 2004 Oct; 31(10):2002-12. PubMed ID: 15468367
[TBL] [Abstract][Full Text] [Related]
51. Effect of regenerative injection therapy on function and pain in patients with knee osteoarthritis: a randomized crossover study.
Dumais R; Benoit C; Dumais A; Babin L; Bordage R; de Arcos C; Allard J; Bélanger M
Pain Med; 2012 Aug; 13(8):990-9. PubMed ID: 22759069
[TBL] [Abstract][Full Text] [Related]
52. Sensitivity of gait parameters to the effects of anti-inflammatory and opioid treatments in knee osteoarthritis patients.
Boyer KA; Angst MS; Asay J; Giori NJ; Andriacchi TP
J Orthop Res; 2012 Jul; 30(7):1118-24. PubMed ID: 22179861
[TBL] [Abstract][Full Text] [Related]
53. Effectiveness of the lidocaine patch 5% on pain qualities in three chronic pain states: assessment with the Neuropathic Pain Scale.
Argoff CE; Galer BS; Jensen MP; Oleka N; Gammaitoni AR
Curr Med Res Opin; 2004; 20 Suppl 2():S21-8. PubMed ID: 15563743
[TBL] [Abstract][Full Text] [Related]
54. Effects of nimesulide on pain and on synovial fluid concentrations of substance P, interleukin-6 and interleukin-8 in patients with knee osteoarthritis: comparison with celecoxib.
Bianchi M; Broggini M; Balzarini P; Franchi S; Sacerdote P
Int J Clin Pract; 2007 Aug; 61(8):1270-7. PubMed ID: 17590218
[TBL] [Abstract][Full Text] [Related]
55. Physical functioning over three years in knee osteoarthritis: role of psychosocial, local mechanical, and neuromuscular factors.
Sharma L; Cahue S; Song J; Hayes K; Pai YC; Dunlop D
Arthritis Rheum; 2003 Dec; 48(12):3359-70. PubMed ID: 14673987
[TBL] [Abstract][Full Text] [Related]
56. A prospective randomized trial on the role of perioperative celecoxib administration for total knee arthroplasty: improving clinical outcomes.
Reuben SS; Buvenandran A; Katz B; Kroin JS
Anesth Analg; 2008 Apr; 106(4):1258-64, table of contents. PubMed ID: 18349203
[TBL] [Abstract][Full Text] [Related]
57. The effect of viscosupplementation on neuromuscular control of the knee in patients with osteoarthritis.
Diracoglu D; Vural M; Baskent A; Dikici F; Aksoy C
J Back Musculoskelet Rehabil; 2009; 22(1):1-9. PubMed ID: 20023357
[TBL] [Abstract][Full Text] [Related]
58. Efficacy and safety of PG201 (Layla(®)) and celecoxib in the treatment of symptomatic knee osteoarthritis: a double-blinded, randomized, multi-center, active drug comparative, parallel-group, non-inferiority, phase III study.
Yoo WH; Yoo HG; Park SH; Baek HJ; Lee YJ; Shim SC; Kang SW; Kim HA; Song JS; Suh CH; Choi SJ; Yoon BY; Tae DN; Ko HS; Song YW
Rheumatol Int; 2014 Oct; 34(10):1369-78. PubMed ID: 24531687
[TBL] [Abstract][Full Text] [Related]
59. Comparison of two different dosages of celecoxib with diclofenac for the treatment of active ankylosing spondylitis: results of a 12-week randomised, double-blind, controlled study.
Sieper J; Klopsch T; Richter M; Kapelle A; Rudwaleit M; Schwank S; Regourd E; May M
Ann Rheum Dis; 2008 Mar; 67(3):323-9. PubMed ID: 17616556
[TBL] [Abstract][Full Text] [Related]
60. Celecoxib 200 mg q.d. is efficacious in the management of osteoarthritis of the knee or hip regardless of the time of dosing.
Stengaard-Pedersen K; Ekesbo R; Karvonen AL; Lyster M
Rheumatology (Oxford); 2004 May; 43(5):592-5. PubMed ID: 14762227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
